NDRG1 and neoplasm: Given our findings that NDRG1 promotes an immunosuppressive tumor microenvironment through lactate‐mediated immune cell regulation, we next explored the therapeutic potential of combining NDRG1 targeting with αPD‐L1 therapy in a LUAD model.